Tuesday 21 May 2019 ,
Tuesday 21 May 2019 ,
Latest News
  • HC seeks reports on Rooppur nuke plant irregularities
  • Opposition could be stronger if Fakhrul would join parliament: Quader
  • Khaleda’s health condition ‘dangerous’: BNP
  • Opposition could be stronger if Fakhrul would join parliament: Quader
  • Govt wants economical development of country : PM
  • BNP names Barrister Rumeen for woman’s parliamentary seat
  • SC to clarify its circular over media reporting: Anisul
  • Cabinet reshuffled for quality works: Quader
20 February, 2019 12:56:16 AM
Print

Beximco Pharma signs deal with US giant Sandoz to acquire 8 ANDAs

STAFF REPORTER, Dhaka
Beximco Pharma 
signs deal with 
US giant Sandoz 
to acquire 8 ANDAs

Beximco Pharmaceuticals Limited, country’s leading manufacturer and exporter of generic pharmaceutical products and active pharmaceutical ingredients, yesterday announced the signing of a definitive agreement with Sandoz Inc., a division of Novartis, to acquire a portfolio of eight Abbreviated New Drug Applications (ANDAs) in the US for an undisclosed amount in cash. Beximco Pharma’s current US portfolio comprises six US Food and Drug Administration (FDA) approved products. Four of these products are currently being exported to the US and two are awaiting regulatory approval. Following this transaction, Beximco Pharma’s US portfolio will consist of 14 approved ANDAs, said a company press release.

Regarding the agreement, Nazmul Hassan MP, Managing Director of Beximco Pharmaceuticals, said, “The acquisition of these ANDAs from Sandoz, a global leader in the generics market, significantly strengthens our position in the US, expanding our portfolio to 14 approved products.The acquisition is expected to provide a major boost to our export sales in the future and we look forward to continuing to build our presence in this important strategic market for Beximco Pharma.”

In August 2016, Beximco Pharma became the first Bangladeshi pharmaceutical company to export medicine to the US market following its manufacturing site approval by the US FDA in June 2015.  

Beximco Pharma is a leading exporter of pharmaceuticals in Bangladesh. The Company currently has a global footprint in more than 50 countries and has been accredited by the leading global regulatory authorities including the US FDA, AGES (EU), TGA (Australia), Health Canada, GCC (Gulf) and TFDA (Taiwan). More than 4,200 employees are driving the company towards achieving its aspiration to be among the most admired companies in the world.  

Since its inception in 1976, Beximco Pharma remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines. Company’s broad portfolio of generics encompasses diverse delivery systems such as tablets, capsules, liquids, semi-solids, intravenous fluids, metered dose inhalers, dry powder inhalers, sterile ophthalmic drops, prefilled syringes, injectables, nebuliser solutions, oral soluble films etc. The Company also undertakes contract manufacturing for multinational and leading global generic pharmaceutical companies.

IK

Comments

Poll
Today's Question »
State minister for power Nasrul Hamid yesterday said everyone to have access to electricity by June. Do you think the feat achievable by the timeframe?
 Yes
 No
 No Comment
Yes 50.5%
No 45.6%
No Comment 3.9%
Video
More Bangladesh Stories
Monitor fruit markets: HC The High Court (HC) yesterday (Monday) directed the authorities concerned to form separate teams to monitor fruit markets and warehouses across the country to see that chemicals are not used in fruits. An HC bench, comprising Justice…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting